HomeCompaniesAnalyticsLogin
Sector: HealthcareIndustry: Medical devices

Abbott Laboratories

Current Price

Analyst Sentiment

28 ratings: Buy

Strong Buy
6
Buy
15
Hold
7
Sell
0
Strong Sell
0

Abbott Laboratories (ABT) is a prominent American multinational healthcare company based in Abbott Park, Illinois, with expertise across a diverse range of sectors, including medical devices, diagnostics, nutritional pro...|

Overview

Market Cap$219.85B
52W High / Low$139 / $109
P/E15.87
PEG4.17
Book Value$29.30
Dividend/Share$2.36
Dividend Yield1.87%
EPS$7.96
Revenue/Share$25.19
OPM19.40%
NPM31.90%
ROA6.79%
ROE30.60%
Gross Profit$24.67B
Forward PE22.52
Price to Sales5.01
Price to Book4.37
EV to Sales5.20
EV to EBITDA19.34
Beta0.72
50D Moving Avg$129.18
200D Moving Avg$130.98
Institutional Holding81.24%
Insider Holding54.20%
Trailing P/E15.87
Qtr EPS GrowthN/A
Qtr Revenue Growth6.90%

Add ratio to table

e.g. Promoter holding

Loading price data...

Earnings Estimates

Analyst consensus EPS and Revenue forecasts.

Metric (B)FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
EPS Estimate (avg)
$5.10$5.23$4.44$4.67$5.15$5.68
Revenue Estimate (avg)
42.2943.2240.0741.9944.6748.22
EPS Revision (30d avg)
+0.4%+0.2%+0.0%-0.0%-0.0%-0.0%

Peer Comparison

Showing 5 peers (Same Industry)
S.No.NameSymbolMarket CapP/EP/BProfit MarginOp. MarginROERev. Growth
1.Medtronic PlcMDT$130.87B27.652.7213.70%20.30%9.82%6.60%
2.Zimmer Biomet Holdings IncZBH$18.66B23.541.4710.10%17.00%6.42%9.70%
3.Edwards Lifesciences CorpEW$49.73B37.154.8523.30%27.40%13.50%14.70%
4.Steris PlcSTE$25.54B37.103.6812.10%18.40%10.10%9.90%
5.Dexcom IncDXCM$25.27B35.819.0916.00%20.10%30.60%21.60%

Quarterly Results

Consolidated Figures in Millions / View Standalone.

Quarter (M)Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25
Sales
10,2419,96410,37710,63510,97410,35811,14211,369
Expenses
3,3943,6373,6193,6083,6083,7564,2364,308
Operating Profit
2,0301,5531,7752,1062,1821,9122,2712,224
OPM %
19.82%15.59%17.11%19.8%19.88%18.46%20.38%19.56%
Other Income
00000000
Interest
-146-37-86-75-61-52-8233
Depreciation
813805805801807756777791
Profit Before Tax
1,7951,4361,6071,9402,0301,7782,1502,180
Tax %
11.2%14.69%18.98%15.15%-354.63%25.48%17.26%24.59%
Net Profit
1,5941,2251,3021,6469,2291,3251,7791,644
EPS
00000000

Profit & Loss

Consolidated Figures in Millions / View Standalone.

Period (M)Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales
20,40520,85327,39030,57831,90434,60843,07543,65340,10941,950
COGS
9,4459,60914,32414,75515,21117,23119,86121,33020,07220,625
Gross Profit
10,96011,24413,06615,82316,69317,37723,21422,32320,03721,325
Gross Profit %
53.71%53.92%47.7%51.75%52.32%50.21%53.89%51.14%49.96%50.83%
Operating Exp
8,0117,99511,09411,97912,10212,08614,01413,96113,60214,474
EBITDA
4,8333,0706,1326,8807,9099,00312,15911,88810,60510,834
Other Income
479-1,3411,4094921515731950200
Interest
-143-205-756-624-724-2168162-314-259
Depreciation
1,4721,3533,0213,2783,0143,3273,5383,2673,2433,218
Profit Before Tax
3,1831,4132,2312,8734,0774,9688,2118,3066,6647,013
Tax Rate %
18.13%24.77%84.18%18.76%9.57%10%13.88%16.53%14.12%-91.1%
Net Profit
4,4231,4004772,3683,6874,4957,0716,9335,72313,402

Balance Sheet

Consolidated Figures in Millions / View Standalone.

Period (M)Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash & Bank
5,00118,6209,4073,8443,8606,8389,7999,8826,8967,616
Investments
5,1653,1021,0861,1391,1631,1311,2661,0541,1821,237
Fixed Assets
-923-956-51-580-723-735-1,446-1,88811,27611,733
Current Assets
8,0308,00110,53710,54611,52713,29313,99015,05415,39115,689
Other Assets
26,72826,24455,27152,22452,06052,02151,58750,33638,46945,139
Total Assets
44,00155,01176,25067,17367,88772,54875,19674,43873,21481,414
Equity Capital
2,1122,23612,98113,55013,70614,10312,64824,70924,86925,153
Reserves
19,09918,30217,91616,97417,38218,68123,15411,97713,73422,511
Borrowing/Debt
9,00122,00627,92419,56619,09919,89019,25117,94615,87315,275
Current Liabilities
5,6265,1477,8898,5008,95411,08411,80012,66512,02411,809
Other Liabilities
5,2944,7969,3398,3858,5338,5718,1216,9226,4906,429
Total Liabilities & Equity
41,13252,48776,04966,97567,67472,32974,97474,21972,99081,177

Cash Flow Statement

Consolidated Figures in Millions / View Standalone.

Period (M)Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash Flow from Operating
2,9663,2035,5706,3006,1367,90110,5339,5817,2618,558
Cash Flow from Investing
406-248-9,618-1,356-1,815-2,215-2,008-1,740-3,133-2,338
Cash Flow from Financing
-2,23611,147-5,281-10,391-4,289-2,779-5,494-7,636-7,091-5,404
Net Cash Flow
93813,619-9,213-5,447322,9073,03120500